Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for BIOLOGISCHE MARKER ZUR IDENTIFIKATION VON PATIENTEN ZUR BEHANDLUNG MIT ABIRATERONACETAT
Details for 2020204903
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2020204903
Title / Product Name
BIOLOGISCHE MARKER ZUR IDENTIFIKATION VON PATIENTEN ZUR BEHANDLUNG MIT ABIRATERONACETAT
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2020204903
EP Publication Number
3795698
E-Number
1551013
Language
EN
PCT Number
Publication Date
24.03.2021 A
01.03.2023 B1
Registration Date
01.03.2023
AT Publication Date
15.03.2023
Application Date
07.05.2015
Registration Number
-
Priorities
12.05.2014
US
201461991710 P
IPC
C12Q 1/68 20060101AFI20210115BHEP
Maximum Duration of Protection
07.05.2035
Owner
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse
BE
Representative
No representatives present
Inventor
SOKOL RICCI, Deborah
P.O. Box Box 300 c/o Janssen Research & Development LLC 920 Route 202
Raritan, New Jersey 08869
US
LI, Weimin
c/o Janssen Research & Development LLC 1400 McKean Road
Spring House, Pennsylvania 19477
US
GORMLEY, Michael
c/o Janssen Research & Development LLC 1400 McKean Road
Spring House, Pennsylvania 19477
US
KARKERA, Jayaprakash
c/o Janssen Research & Development LLC 1400 McKean Road
Spring House, Pennsylvania 19477
US
SCHAFFER, Michael
c/o Janssen Research & Development LLC Welsh & McKean Roads
Spring House, Pennsylvania 19477
US